C-suite remuneration across a dozen leading pharma companies in India rose in 2020-21 as top executives steered their organizations through pandemic-related disruptions and challenges to keep things moving. CEOs and managing directors of domestic firms continued to draw sizeably higher earnings overall versus their peers in foreign-listed entities in India.
Cadila Healthcare’s managing director Sharvil Patel, the son of chairman Pankaj Patel, led the earnings chart yet again, taking home INR262.50m ($3
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?